References
- Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 87(3), 755–763 (1993).
- Chen J, Normand SL, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998–2008. JAMA 306(15), 1669–1678 (2011).
- Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N. Engl. J. Med. 360(14), 1418–1428 (2009).
- Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc. Imaging 4(1), 98–108 (2011).
- Kramer DG, Trikalinos TA, Kent DM et al. Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach quantitative evaluation. J. Am. Coll. Cardiol. 56, 392–406 (2010).
- Shroyer AL, Collins JF, Grover FL. Evaluating clinical applicability: the STICH trial’s findings. J. Am. Coll. Cardiol. 56(6), 508–509 (2010).
- Buckberg GD, Athanasuleas CL. The STICH trial: misguided conclusions. J. Thorac. Cardiovasc. Surg. 138(5), 1060–1064.e2 (2009).
- Klein MD, Herman MV, Gorlin R. A hemodynamic study of left ventricular aneurysm. Circulation 35(4), 614–630 (1967).
- Mazzaferri EL Jr, Gradinac S, Sagic D et al. Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: results of the Percutaneous Ventricular Restoration in Chronic Heart failure Patients Trial. Am. Heart J. 163(5), 812–820.e1 (2012).